BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Diagnosis
14 results:

  • 1. Frequent Overexpression of her3 in Brain Metastases from Breast and lung cancer.
    Tomasich E; Steindl A; Paiato C; Hatziioannou T; Kleinberger M; Berchtold L; Puhr R; Hainfellner JA; Müllauer L; Widhalm G; Eckert F; Bartsch R; Heller G; Preusser M; Berghoff AS
    Clin Cancer Res; 2023 Aug; 29(16):3225-3236. PubMed ID: 37036472
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of cancer: A Review.
    Unnisa A; Chettupalli AK; Hussain T; Kamal MA
    Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Integration of Liquid Biopsies into Clinical Laboratory Applications via NGS in cancer Diagnostics.
    Sonmezler O; Boga I; Bisgin A
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390404
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MiR-519d targets her3 and can be used as a potential serum biomarker for non-small cell lung cancer.
    Wang A; Zhang H; Wang J; Zhang S; Xu Z
    Aging (Albany NY); 2020 Mar; 12(6):4866-4878. PubMed ID: 32170048
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical manifestations and STK11 germline mutations in Taiwanese patients with Peutz-Jeghers syndrome.
    Chiang JM; Chen TC
    Asian J Surg; 2018 Sep; 41(5):480-485. PubMed ID: 28869103
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prevalence, clinicopathologic characteristics, and molecular associations of EGFR exon 20 insertion mutations in East Asian patients with lung adenocarcinoma.
    Pan Y; Zhang Y; Li Y; Hu H; Wang L; Li H; Wang R; Ye T; Luo X; Zhang Y; Li B; Cai D; Shen L; Sun Y; Chen H
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S490-6. PubMed ID: 24419753
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The c-Met inhibitors: a new class of drugs in the battle against advanced nonsmall-cell lung cancer.
    Sgambato A; Casaluce F; Maione P; Rossi A; Rossi E; Napolitano A; Palazzolo G; Bareschino MA; Schettino C; Sacco PC; Ciardiello F; Gridelli C
    Curr Pharm Des; 2012; 18(37):6155-68. PubMed ID: 22873759
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Gene expression from bronchoscopy obtained tumour samples as a predictor of outcome in advanced inoperable lung cancer.
    Suwinski R; Klusek A; Tyszkiewicz T; Kowalska M; Szczesniak-Klusek B; Gawkowska-Suwinska M; Tukiendorf A; Kozielski J; Jarzab M
    PLoS One; 2012; 7(7):e41379. PubMed ID: 22848476
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma.
    Stav D; Bar I; Sandbank J
    Int J Biol Markers; 2007; 22(2):108-13. PubMed ID: 17549666
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
    Zech VF; Dlaska M; Tzankov A; Hilbe W
    Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation.
    Blons H; Côté JF; Le Corre D; Riquet M; Fabre-Guilevin E; Laurent-Puig P; Danel C
    Am J Surg Pathol; 2006 Oct; 30(10):1309-15. PubMed ID: 17001163
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Predicting the outcome of chemotherapy for lung cancer.
    Rosell R; Cecere F; Santarpia M; Reguart N; Taron M
    Curr Opin Pharmacol; 2006 Aug; 6(4):323-31. PubMed ID: 16765644
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Receptor tyrosine kinase and p16/CDKN2 expression in a case of tripe palms associated with non-small-cell lung cancer.
    Krähn G; Greulich KM; Bezold G; Dieterle C; Wolff H; Peter RU
    Dermatology; 1999; 199(4):290-5. PubMed ID: 10640836
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis.
    Brandt B; Vogt U; Schlotter CM; Jackisch C; Werkmeister R; Thomas M; von Eiff M; Bosse U; Assmann G; Zänker KS
    Gene; 1995 Jun; 159(1):35-42. PubMed ID: 7607571
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.